Dorman Products, Inc. (DORM) Stock Forecast
Data as of Oct 31, 2026Consumer Cyclical · Current price $135.24 (+1.17%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | Bret Jordan | Jefferies | $140.00 | +3.5% |
| Sep 18, 2025 | Tristan Thomas-Martin | BMO Capital | $180.00 | +33.1% |
| Aug 22, 2025 | David Lantz | Wells Fargo | $175.00 | +29.4% |
Top Analysts Covering DORM
DORM vs Sector & Market
| Metric | DORM | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.48 | 2.41 |
| Analyst Count | 5 | 12 | 19 |
| Target Upside | +22.0% | +248.0% | +21.5% |
| P/E Ratio | 21.81 | 16.42 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $586M | $593M | $597M | 2 |
| 2027-03-31 | $549M | $555M | $559M | 2 |
| 2027-06-30 | $605M | $612M | $617M | 2 |
| 2027-09-30 | $605M | $612M | $617M | 2 |
| 2027-12-31 | $607M | $614M | $619M | 2 |
| 2028-12-31 | $2.58B | $2.58B | $2.58B | 1 |
| 2029-12-31 | $2.67B | $2.70B | $2.72B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.41 | $2.45 | $2.47 | 1 |
| 2027-03-31 | $1.87 | $1.90 | $1.92 | 1 |
| 2027-06-30 | $2.12 | $2.15 | $2.18 | 1 |
| 2027-09-30 | $2.55 | $2.59 | $2.62 | 1 |
| 2027-12-31 | $2.57 | $2.61 | $2.64 | 1 |
| 2028-12-31 | $9.88 | $10.01 | $10.12 | 3 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 2 |
Frequently Asked Questions
What is the analyst consensus for DORM?
The consensus among 5 analysts covering Dorman Products, Inc. (DORM) is Buy with an average price target of $165.00.
What is the highest price target for DORM?
The highest price target for DORM is $180.00, set by Tristan Thomas-Martin at BMO Capital on 2025-09-18.
What is the lowest price target for DORM?
The lowest price target for DORM is $140.00, set by Bret Jordan at Jefferies on 2026-03-02.
How many analysts cover DORM?
5 analysts have issued ratings for Dorman Products, Inc. in the past 12 months.
Is DORM a buy or sell right now?
Based on 5 analyst ratings, DORM has a consensus rating of Buy (2.00/5) with a +22.0% upside to the consensus target of $165.00.
What are the earnings estimates for DORM?
Analysts estimate DORM will report EPS of $2.45 for the period ending 2026-12-31, with revenue estimated at $593M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.